Table 2 Multivariate Regression Analysis for the determinants that influenced the choroidal structures*.
SFCT, B (β) [95% CI], μm | p | Total choroidal area, B (β) [95% CI], 103 μm2 | p | Luminal area, B (β) (95% CI), 103 μm2 | p | Stromal area, B (β) (95% CI), 103 μm2 | p | L/S ratio, B (β) (95% CI) | p | |
|---|---|---|---|---|---|---|---|---|---|---|
Adjusted R2 | 0.390 | 0.375 | 0.338 | 0.413 | 0.084 | |||||
Age | −2.7 (−0.417) [−3.5 to −1.9] | <0.001 | −14.6 (−0.423) [−18.8 to −10.4] | <0.001 | −9.8 (−0.396) [−12.8 to −6.7] | <0.001 | −4.9 (−0.455) [−6.1 to −3.6] | <0.001 | ||
axial length | −34.8 (−0.414) [−44.9 to −24.8] | <0.001 | −165.6 (−0.372) [−218.3 to −112.9] | <0.001 | −121.6 (−0.382) [−160.3 to −82.8] | <0.001 | −45.2 (−0.326) [−61.7 to −28.6] | <0.001 | −0.054 (−0.206) [−0.089 to −0.019] | 0.003 |
Sex (women) | −23.4 (−0.135) [−43.9 to −2.9] | 0.026 | −145.3 (−0.159) [−253.2 to −37.3] | 0.020 | −112.3 (−0.172) [−191.7 to −32.9] | 0.006 | −27.9 (−0.098) [−61.5 to 5.7] | 0.103 | ||
Albumin index† | 0.004 (0.087) [−0.002 to 0.010] | 0.160 | 34.3 (0.130) [2.6 to 66.0] | 0.034 | 22.1 (0.117) [−1.2 to 45.3] | 0.063 | 14.5 (0.177) [1.8 to 27.2] | 0.025 | ||
Stage of DR, NDR | 0 | 0 | 0 | 0 | ||||||
mNDR | 35.9 (0.173) [6.8 to 65.1] | 0.016 | 200.2 (0.181) [46.3 to 354.1] | 0.011 | 164.7 (0.209) [52.0 to 277.3] | 0.004 | 30.6 (0.089) [−17.0 to 78.1] | 0.206 | ||
Severe NPDR | 53.9 (0.239) [22.6 to 84.8] | 0.001 | 284.9 (0.240) [120.2 to 449.7] | <0.001 | 204.4 (0.240) [85.5 to 323.3] | 0.001 | 81.4 (0.220) [30.7 to 132.2] | 0.002 | ||
PDR without PRP | 54.2 (0.258) [21.9 to 86.5] | 0.001 | 284.8 (0.256) [114.0 to 455.7] | 0.002 | 195.3 (0.245) [75.6 to 315.0] | 0.002 | 89.9 (0.259) [37.0 to 142.7] | 0.001 | ||
PDR with PRP | −4.7 (−0.023) [−34.0to 24.6] | 0.753 | −4.7 (−0.004) [−161.8 to 152.4] | 0.758 | 10.7 (0.014) [−103.6 to 125.1] | 0.853 | −28.3 (−0.083) [−76.7 to 20.1] | 0.250 | ||
DME (present) | 4.5 (0.026) [−16.7 to 25.8] | 0.673 | 33.4 (0.036) [−78.0 to 144.9] | 0.555 | −45.4 (−0.158) [−130.0 to 39.5] | 0.292 | ||||
Hypertension (present) | −132.5 (−0.139) [−246.3 to −18.6] | 0.023 | −98.9 (−0.145) [−182.5 to −15.4] | 0.021 | ||||||
Type of DME, absent | 0 | |||||||||
Sponge-like swelling | 9.1 (0.021) [−58.8 to 77.1] | 0.791 | ||||||||
Cystoid macular edema | 74.5 (0.224) [−14.0 to 163.0] | 0.098 | ||||||||
Serous retinal detachment | 59.4 (0.116) [−34.8 to 153.6] | 0.215 | ||||||||
Serum albumin | 12.2 (0.051) [−24.9 to 49.4] | 0.516 | ||||||||
BCVA | −0.198 (−0.174) [−0.363 to 0.032] | 0.019 | ||||||||
CMT | −0.000 (−0.108) [−0.001 to 0.000] | 0.144 |